Biography
- Division:
- Division of Translational and Clinical Sciences – DTCS
- Review Branch:
- Cancer Diagnosis, Prevention & Therapeutics – CDPT
Dr. Shree Ram Singh received his Ph.D. in genetics from the Banaras Hindu University, India, and was a scientist at Goethe University Frankfurt, Germany. After postdoctoral training at Haifa University, Israel, and at the National Cancer Institute (NCI), he became a staff scientist at NCI. He has performed research in the broader area of cancer biology, stem cell biology, cell signaling, genetics, genomics, cancer metabolism, anti-tumor immunity, tumor microenvironment, and anti-cancer drug discovery. Dr. Singh has published 9 books and over 150 research articles in prestigious journals such as Nature, Cell Stem Cell, Developmental Cell, Nature Communications, Oncogene, Cancer Letters, and Cell Reports. Prior to joining CSR, he was a scientific review officer at NCI. He has several years of experience in managing the peer review process of a large breadth of funding mechanisms in the broader area of cancer research involving multi-project and single-project cooperative agreements, research training grants, clinical trials, and initiatives for basic, clinical, and translational research.
